MYC and familial pancreatic carcinoma: Interestingly, the pharmacological inhibition of c-Myc in turn downregulated mutp53 in pancreatic cancer cells (Figure 4F), as previously reported [21], indicating that mutp53 and c-Myc establish a cross-talk that SAHA and the even better combination SAHA/5-AZA were able to interrupt.